Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
IF the stock market is any guide, Sharvil Patel has just inherited one of the top generic drug manufacturers in the world. Now, he just has to figure out how to keep it that way. Even as the copycat drug business reeled from increased regulatory scrutiny, withering competition in the United...